Joseph Marks serves as Executive at Augmedix, Inc., where they oversee executive responsibilities. Since joining the company, Joseph Marks has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 16, 2023 involved exercising options for 52,632 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jun 16, 2023 | AUGX | $0 | Option Exercise | 52,632 | $N/A | Discretionary |
Joseph Marks currently holds 52,632 shares of Augmedix, Inc. (AUGX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joseph Marks has been a net neutral trader of AUGX stock. They have purchased $0 and sold $0 worth of shares.
Joseph Marks's most recent insider trade was on Jun 16, 2023, when they sold 52,632 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted